Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

被引:0
|
作者
Emel Yaman
Aytug Uner
Ozlem Er
Ugur Coskun
Suleyman Buyukberber
Mustafa Dikilitas
Mevlude Polat
Deniz Yamac
Ali Osman Kaya
Ramazan Yildiz
Banu Ozturk
Mustafa Benekli
机构
[1] Gazi University Medical School,Department of Medical Oncology
[2] Erciyes University Medical School,Department of Medical Oncology
来源
Medical Oncology | 2007年 / 24卷
关键词
Metastatic colorectal cancer; Oxaliplatin; Capecitabine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:431 / 435
页数:4
相关论文
共 50 条
  • [1] Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
    Yaman, Emel
    Uner, Aytug
    Er, Ozlem
    Coskun, Ugur
    Buyukberber, Suleyman
    Dikilitas, Mustafa
    Polat, Mevlude
    Yamac, Deniz
    Kaya, Ali Osman
    Yildiz, Ramazan
    Ozturk, Barm
    Benekli, Mustafa
    MEDICAL ONCOLOGY, 2007, 24 (04) : 431 - 435
  • [2] Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
    Coskun, U.
    Buyukberber, S.
    Yaman, E.
    Uner, A.
    Er, O.
    Ozkan, M.
    Dikilitas, M.
    Oguz, M.
    Yildiz, R.
    Yamac, D.
    Ozturk, B.
    Kaya, A. O.
    Benekli, M.
    NEOPLASMA, 2008, 55 (01) : 65 - 70
  • [3] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [4] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [5] The results of xelox (capecitabine plus oxaliplatin) in metastatic colorectal cancer: A single center experience
    Yaman, Emel
    Yildiz, Ramazan
    Kaya, A. Osman
    Ozturk, Banu
    Buyukberber, Suleyman
    Coskun, Ugur
    Benekli, Mustafa
    Yamac, Deniz
    Uner, Aytug
    ANNALS OF ONCOLOGY, 2006, 17 : 129 - 129
  • [6] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
  • [7] Two doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancer
    Moreno-Solorzano, Isabel
    Ibeas-Rollan, Rafael
    Monzo-Planella, Mariano
    Moreno-Solorzano, Jose
    Martinez-Rodenas, Francisco
    Pou-Sanchis, Edmon
    Hernandez-Borlan, Raquel
    Navarro-Vigo, Marta
    Ortigosa-Rodriguez, Silvia
    Gel-Moreno, Bernat
    CLINICAL COLORECTAL CANCER, 2007, 6 (09) : 634 - 640
  • [8] Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer
    Li, Yu Hong
    Luo, Hui Yan
    Wang, Feng Hua
    Wang, Zhi Qiang
    Qiu, Miao Zhen
    Shi, Yan Xia
    Xiang, Xiao Juan
    Chen, Xiao Qing
    He, You Jian
    Xu, Rui Hua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (04) : 503 - 510
  • [9] Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer
    Yu Hong Li
    Hui Yan Luo
    Feng Hua Wang
    Zhi Qiang Wang
    Miao Zhen Qiu
    Yan Xia Shi
    Xiao Juan Xiang
    Xiao Qing Chen
    You Jian He
    Rui Hua Xu
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 503 - 510
  • [10] Capecitabine plus oxaliplatin in metastatic colorectal cancer
    Cassidy, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 5043 - 5045